[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370060-105":59,"doc-detail-370060-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-retrospective-study-of-post-radiation-sarcoma-from-three-institutions-in-japan-with-a-review-of-the-literature","A retrospective study of post-radiation sarcoma from three institutions in Japan with a review of the literature","","This retrospective study investigated incidence, clinical characteristics, and outcomes of post-radiation sarcoma (PRS), a rare but severe complication after radiotherapy. The analysis covered 14 PRS patients treated across three Japanese institutions from January 2000 to January 2025, applying widely accepted diagnostic criteria. Patients with multiple primary cancer types were included, with a median latency of 9.9 years and a median pre-diagnosis radiation dose of 52.5 Gy. Median overall survival was 2.6 years and 5-year overall survival probability 46.8%. Prognosis tended to associate with complete resection (P=0.09), and a literature review suggested increasing PRS cases following radiotherapy for prostate cancer, emphasizing early detection and long-term monitoring.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-retrospective-study-of-post-radiation-sarcoma-from-three-institutions-in-japan-with-a-review-of-the-literature/370060/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-retrospective-study-of-post-radiation-sarcoma-from-three-institutions-in-japan-with-a-review-of-the-literature/370060.png","ImageObject",300,407,{"name":92,"@type":93},"hdkawk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What diagnostic criteria define post-radiation sarcoma in this study?","Question",{"text":112,"@type":113},"PRS was diagnosed when at least three years elapsed since the last irradiation, the sarcoma developed within the irradiated lesion, and histology was distinct from the primary tumor.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many PRS patients were analyzed and over what period?",{"text":117,"@type":113},"Fourteen patients were enrolled and cases were collected from January 2000 to January 2025 across three institutions in Japan.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main outcome measures reported?",{"text":121,"@type":113},"Overall survival was the primary endpoint, with secondary endpoints including patient characteristics, treatment approaches, and prognostic factors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370060,1790220060,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","ORIGINAL PAPER  \nNagoya J. Med. Sci. 87. 747–765, 2025 doi:10.18999/nagjms.87.4.747  \nA retrospective study of post-radiation sarcoma from three institutions in Japan with a review of the literature  \nTomohiro Miyazaki 1, Naoki Oike 1, Takashi Ariizumi 1, Yudai Murayama 1, Hiroshi Hatano2, Tetsuro Yamagishi2, Yoshiaki Tei3, Akira Ogose3 and Hiroyuki Kawashima 1  \n1Department of Orthopedics, Graduate School of Medical and Dental Sciences, Niigata University,  \nNiigata, Japan  \n2Department of Orthopedic Oncology, Niigata Cancer Center Hospital, Niigata, Japan 3Department of Orthopedic Surgery, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minami-Uonuma, Japan  \nABSTRACT  \nThis study investigated incidence, clinical characteristics, and outcomes of post-radiation sarcoma, a rare but severe complication following radiotherapy. Post-radiation sarcoma is a malignant tumor arising within irradiated areas after a latency period, histologically different from the primary tumor. We retrospectively analyzed cases from January 2000 to January 2025 at three institutions in Japan, employing widely accepted diagnostic criteria. Patient characteristics, treatment details, oncologic outcomes, and prognostic factors were evaluated. Our study included 14 patients with various primary cancers, including three breast cancers, three prostate cancers, and one each of other cancer types. Among the cases, six had osteosarcoma, six had undifferentiated pleomorphic sarcoma, one had chondrosarcoma, and one had malignant peripheral nervesheath tumor, predominantly occurring in the trunk. The median latency period from last irradiation to diagnosis was 9.9 years (range, 3.0–19.5 years) . The median total radiation dose administered before postradiation sarcoma diagnosis was 52.5 Gy (range, 12–74 Gy) . The median overall survival and probability of 5-year overall survival were 2.6 years and 46.8%, respectively. The only factor that tended to correlate with prognosis was whether complete resection was achieved (P = 0.09) . A literature review confirmed an increasing number of post-radiation sarcoma cases following radiotherapy for prostate cancer in recent years. The incidence of post-radiation sarcoma is expected to rise alongside the number of patients undergoing radiotherapy. Early detection and appropriate treatment are essential to improve prognosis, highlighting the need for careful long-term monitoring of patients receiving radiotherapy for post-radiation sarcoma.  \nKeywords: post-radiation sarcoma, prostate cancer, radiotherapy, secondary malignancy  \nAbbreviation:  \nPRS: post-radiation sarcoma  \nThis is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \nReceived: March 10, 2025; Accepted: May 9, 2025  \nCorresponding Author: Naoki Oike, MD, PhD  \nDepartment of Orthopedics, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan  \nTel: +81-25-227-2272, E-mail: naoki-oike@med.niigata‑[u.ac.jp](u.ac.jp)  \nTomohiro Miyazaki et al  \nINTRODUCTION  \nPost-radiation sarcoma (PRS) is a rare but serious malignant tumor that develops within irradiated tissues several years after radiotherapy and is associated with a poor prognosis. The reported incidence of PRS ranges from 0.03% to 0.8%,1 with the risk increasing over time. Since Beck and Marsch first described PRS,2 several diagnostic criteria of PRS have been proposed.3-5 The most widely accepted criteria require that the sarcoma arises within a previously irradiated area, develops after a latency period of at least several years, and is histologically distinct from the primary tumor.3,4 Advancements in cancer treatment, including radiotherapy, have significantly improve","cbCaikBJQuG9t42b","https://ap.wps.com/l/cbCaikBJQuG9t42b","pdf",938442,"English","# Abstract\n# Introduction\n# Materials and Methods\n## Study population\n## Ethical approval and endpoints\n# Results\n# Discussion","[{\"question\":\"What diagnostic criteria define post-radiation sarcoma in this study?\",\"answer\":\"PRS was diagnosed when at least three years elapsed since the last irradiation, the sarcoma developed within the irradiated lesion, and histology was distinct from the primary tumor.\"},{\"question\":\"How many PRS patients were analyzed and over what period?\",\"answer\":\"Fourteen patients were enrolled and cases were collected from January 2000 to January 2025 across three institutions in Japan.\"},{\"question\":\"What were the main outcome measures reported?\",\"answer\":\"Overall survival was the primary endpoint, with secondary endpoints including patient characteristics, treatment approaches, and prognostic factors.\"}]","A retrospective study of post-radiation sarcoma from three institutions in Japan with a review of the literature | PDF",1790186533,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/286b1c8624100aafa14561c80fb0731f.webp",983,1387,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6590941f76ba4b79b285ec657ed8738a.webp",982,1386,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9fe4c96fb8f82ae90a29102723344da.webp",981,1385,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a02f4a69488a7643104707a6c853179.webp",980,1383]